Application | Comment | Organism |
---|---|---|
medicine | specific inhibition of either the CYP2C epoxygenase or the CYP4A omega-hydroxylase abrogates peroxisomal proliferation induced by the hypolipidemic drug cirpofibrate | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hepatocyte | cultured hepatocyte | Rattus norvegicus | - |
Synonyms | Comment | Organism |
---|---|---|
CYP4A | - |
Rattus norvegicus |
Organism | Comment | Expression |
---|---|---|
Rattus norvegicus | in ciprofibrate-treated cells, CYP4A expression increases by 1.5- to 1.8fold | up |
General Information | Comment | Organism |
---|---|---|
physiological function | omega-hydroxylated eicosatrienoic acids may serve as endogenous peroxisome proliferator-activated receptor alpha ligands. P450 arachidonic acid monooxygenases such as CYP2C epoxygenase and CYP4A omega-hydroxylase participate in ciprofibrate-induced peroxisomal proliferation and the activation of peroxisome proliferator-activated receptor alpha downstream targets | Rattus norvegicus |